Project aims: to address the specific access needs within co-infected key populations to hepatitis prevention, testing, treatment and care services and to improve the capacity of key community leaders to further educate and support local community members and improve community involvement in treatment related advocacy and activism.
Main activities: literature search & research about needs of key populations, existing programmes, national policies and awareness of medical doctors, identifying of main barriers to seek care, providing recommendations to improve access, developing training material, educating key community leaders and providing small grants for communities to develop follow-up projects at local level
Project leader: EATG
EATG participation: Initiative independently developed by EATG. The project will be carried out in collaboration with local and European key community organisations.
Duration: October 2016 – May/June 2017
Main funding source/programme: Bristol-Myers Squibb